Major Investment Targets Research Gaps
The Bill & Melinda Gates Foundation announced a $2.5 billion commitment over the next five years to accelerate research in women’s health. The funding, which includes several multi-million dollar grants for Boston-area institutions, aims to address the longstanding underinvestment in conditions primarily affecting women, such as maternal health, STIs, and preeclampsia.
This initiative represents one of the largest cumulative investments in women’s health R&D to date, but experts caution that far more is needed to truly close the gender research gap.
Boston Institutions Among Key Beneficiaries
Hospitals, universities, and biotech startups across the Boston region are receiving significant backing from the Gates Foundation as federal research funding contracts under policy shifts from the Trump administration. Agencies like the National Institutes of Health and National Science Foundation have scaled back, leaving a gap the foundation now seeks to partially fill.
Among the recipients:
- Tufts University: Funding will go toward maternal nutrition programs.
- Fenway Health: Backed for data collection and STI advocacy efforts.
- Harvard University: Several schools will use the funds to advance studies on vaginal microbiomes, preeclampsia, and contraceptive technology.
Comanche Biotech Secures $3 Million for Preeclampsia Research
Comanche, a biopharma startup based in Concord, previously supported by the foundation, received a new $3 million grant. The funds will help continue development of RNA-based therapies targeting pre-term preeclampsia and support expansion of its research internationally. Rasa Izadnegahdar, director of maternal, newborn, child nutrition and health at the foundation, confirmed the investment aligns with broader efforts to boost innovation in neglected women’s health areas.
Comanche CEO Scott Johnson noted the company plans to leverage the funding to scale its efforts globally, furthering its mission to bring solutions to underserved populations.
Experts Say More Support Still Needed
Despite the magnitude of the Gates Foundation’s initiative, stakeholders emphasize the need for broader investment. Izadnegahdar acknowledged that while this is the largest concentrated push in women’s health R&D to date, the overall funding ecosystem remains insufficient.
“I don’t think it even starts to scratch the surface,” he said. The sentiment echoes growing concerns that meaningful progress in gender-based health equity will require consistent, systemic support across public and private sectors.